Combined PET-FDG and USPIO-enhanced MR imaging in patients with symptomatic moderate carotid artery stenosis

T Y Tang1, R R Moustafa, S P Howarth

  • 1Cambridge Vascular Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. tt279@cam.ac.uk

Abstract

Insights

Positron emission tomography with FDG (18F) and USPIO-enhanced MRI can identify carotid plaque inflammation. Combined use may aid in selecting patients for carotid revascularization surgery.

Area of Science:

  • Cardiovascular Imaging
  • Neurology
  • Radiology

Background:

  • Carotid atheroma inflammation is a key risk factor for high-risk plaques.
  • Positron emission tomography with 18F-fluorodeoxyglucose (PET-FDG) and ultrasmall superparamagnetic iron oxide nanoparticle-enhanced magnetic resonance imaging (USPIO-enhanced MRI) are emerging techniques for assessing this inflammation.
  • The combined application of these imaging modalities has not been previously investigated.

Observation:

  • Two patients with stroke and 50% carotid stenosis underwent both PET-FDG and USPIO-enhanced MRI.
  • The imaging results from both techniques were concordant.
  • The findings suggest that both PET-FDG and USPIO-enhanced MRI reflect similar metabolic processes within the carotid plaque.

Findings:

  • The study demonstrated concordant and complementary results between PET-FDG and USPIO-enhanced MRI in assessing carotid atheroma inflammation.
  • Both imaging modalities appear to reflect similar underlying metabolic processes in the plaque.

Implications:

  • Current patient selection for carotid revascularization primarily relies on stenosis severity.
  • PET-FDG and USPIO-enhanced MRI, by identifying inflammatory activity, could serve as potential surrogate risk markers.
  • Further research correlating plaque inflammation with clinical symptom development is needed to establish their role in patient selection for carotid surgery.